These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical standards for the management of adverse effects during treatment for TB. Singh KP; Carvalho ACC; Centis R; D Ambrosio L; Migliori GB; Mpagama SG; Nguyen BC; Aarnoutse RE; Aleksa A; van Altena R; Bhavani PK; Bolhuis MS; Borisov S; van T Boveneind-Vrubleuskaya N; Bruchfeld J; Caminero JA; Carvalho I; Cho JG; Davies Forsman L; Dedicoat M; Dheda K; Dooley K; Furin J; García-García JM; Garcia-Prats A; Hesseling AC; Heysell SK; Hu Y; Kim HY; Manga S; Marais BJ; Margineanu I; Märtson AG; Munoz Torrico M; Nataprawira HM; Nunes E; Ong CWM; Otto-Knapp R; Palmero DJ; Peloquin CA; Rendon A; Rossato Silva D; Ruslami R; Saktiawati AMI; Santoso P; Schaaf HS; Seaworth B; Simonsson USH; Singla R; Skrahina A; Solovic I; Srivastava S; Stocker SL; Sturkenboom MGG; Svensson EM; Tadolini M; Thomas TA; Tiberi S; Trubiano J; Udwadia ZF; Verhage AR; Vu DH; Akkerman OW; Alffenaar JWC; Denholm JT Int J Tuberc Lung Dis; 2023 Jul; 27(7):506-519. PubMed ID: 37353868 [TBL] [Abstract][Full Text] [Related]
7. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. Noeske J; Voelz N; Fon E; Abena Foe JL BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea. Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246 [TBL] [Abstract][Full Text] [Related]
11. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease. Visca D; Centis R; Pontali E; Zampogna E; Russell AM; Migliori GB; Andrejak C; Aro M; Bayram H; Berkani K; Bruchfeld J; Chakaya JM; Chorostowska-Wynimko J; Crestani B; Dalcolmo MP; D'Ambrosio L; Dinh-Xuan AT; Duong-Quy S; Fernandes C; García-García JM; de Melo Kawassaki A; Carrozzi L; Martinez-Garcia MA; Martins PC; Mirsaeidi M; Mohammad Y; Naidoo RN; Neuparth N; Sese L; Silva DR; Solovic I; Sooronbaev TM; Spanevello A; Sverzellati N; Tanno L; Tiberi S; Vasankari T; Vasarmidi E; Vitacca M; Annesi-Maesano I Int J Tuberc Lung Dis; 2023 Oct; 27(10):729-741. PubMed ID: 37749839 [TBL] [Abstract][Full Text] [Related]
12. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China. Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292 [TBL] [Abstract][Full Text] [Related]
13. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study. Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study. Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399 [TBL] [Abstract][Full Text] [Related]
18. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877 [TBL] [Abstract][Full Text] [Related]